IMR — Imricor Medical Systems Balance Sheet
0.000.00%
- AU$428.23m
- AU$435.07m
- $0.96m
Annual balance sheet for Imricor Medical Systems, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 25.1 | 18.5 | 5.69 | 0.832 | 15.7 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.223 | 0.095 | 0.126 | 0.393 | 0.345 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 28.9 | 22.7 | 9.68 | 3.94 | 18.3 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 3.89 | 3.6 | 3.56 | 3.17 | 2.6 |
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 33.6 | 26.9 | 13.7 | 8.31 | 21.6 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2.3 | 2.74 | 2.07 | 4.57 | 2.36 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 4.75 | 4.46 | 6.19 | 17.1 | 29 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 28.8 | 22.4 | 7.51 | -8.75 | -7.38 |
Total Liabilities & Shareholders' Equity | 33.6 | 26.9 | 13.7 | 8.31 | 21.6 |
Total Common Shares Outstanding |